| Metric | Q2 2022 | Q1 2022 | Q2 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | — | -5.0% | — |
| Op. Income | -$579M | $184M | — | -414.7% | — |
| Gross Margin | 66.0% | 66.6% | — | -0.6pp | — |
| Net Margin | -46.0% | 7.0% | — | -53.1pp | — |
| EPS (Diluted) | $-3.41 | $0.54 | — | -731.5% | — |
| Free Cash Flow | $54M | $111M | — | -51.4% | — |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $395M |
| GROSS PROFIT | $767M |
| R&D Expenses | $327M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $410M |
| Other Expenses | $609M |
| Operating Expenses | $1.3B |
| Cost & Expenses | $1.7B |
| OPERATING INCOME | -$579M |
| Interest Income | $1M |
| Interest Expense | $6M |
| Other Income/Expenses | -$58M |
| INCOME BEFORE TAX | -$637M |
| Income Tax Expense | -$102M |
| Net Income from Continuing Ops | -$535M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | -$535M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | -$535M |
| D&A | $94M |
| EBIT | -$631M |
| EBITDA | -$537M |
| EPS | -$3 |
| EPS Diluted | -$3 |
| Item | Amount |
|---|---|
| Net Income | -$535M |
| Depreciation & Amortization | $94M |
| Stock-Based Compensation | $91M |
| Deferred Income Tax | -$13M |
| Other Non-Cash Items | $83M |
| Change in Working Capital | $405M |
| OPERATING CASH FLOW | $125M |
| Capital Expenditure | -$71M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$9M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$85M |
| NET CASH FROM INVESTING | -$165M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$5M |
| NET CASH FROM FINANCING | -$5M |
| FREE CASH FLOW | $54M |
| Net Change in Cash | -$62M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.3B |
| Short-Term Investments | $38M |
| Net Receivables | $660M |
| Inventory | $518M |
| Other Current Assets | $386M |
| TOTAL CURRENT ASSETS | $2.9B |
| PP&E (Net) | $1.7B |
| Goodwill | $7.2B |
| Intangible Assets | $3.2B |
| Long-Term Investments | $229M |
| Tax Assets | $0 |
| Other Non-Current Assets | $220M |
| TOTAL NON-CURRENT ASSETS | $12.6B |
| TOTAL ASSETS | $15.4B |
| Account Payables | $282M |
| Short-Term Debt | $1.3B |
| Deferred Revenue | $226M |
| Other Current Liabilities | $769M |
| TOTAL CURRENT LIABILITIES | $2.9B |
| Long-Term Debt | $495M |
| Deferred Revenue NC | $65M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $788M |
| TOTAL NON-CURRENT LIABILITIES | $2.1B |
| TOTAL LIABILITIES | $5.0B |
| Common Stock | $2M |
| Additional Paid-In Capital | $9.0B |
| Retained Earnings | $5.1B |
| Treasury Stock | -$3.7B |
| Accum. Other Comp. Income | $30M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $10.4B |
| Minority Interest | $0 |
| TOTAL EQUITY | $10.4B |
| TOTAL LIABILITIES & EQUITY | $15.4B |
| Total Debt | $2.6B |
| Net Debt | $1.3B |
